Life & Health Sciences
Mechanical engineering researcher gets $1.3M grant to study preventing post-traumatic osteoarthritisJuly 26, 2016
The National Institutes of Health has awarded a $1.3 million grant to Diane Wagner, an associate professor of mechanical engineering with the School of Engineering and Technology at Indiana University-Purdue University Indianapolis, to evaluate a new method of strengthening damaged cartilage, preventing it from progressing to a debilitating form of arthritis.
IU-based startup Arrhythmotech awarded $1.47M NIH grant to study atrial fibrillation, nerve activityJuly 21, 2016
The life sciences company based on Indiana University technology will use the two-year grant from the National Institutes of Health to determine if nerve activity is associated with atrial fibrillation, a common heart-rhythm disorder.
July 19, 2016
An Indiana University technology that could accelerate work conducted by drug discovery researchers, cancer biologists and vascular biologists has been licensed to a life science company in the United Kingdom.
July 14, 2016
Officials at Indiana University Research and Technology Corp. have reported that four startups were launched by researchers at IUPUI and IU School of Medicine through the Spin Up program in the 2015-16 fiscal year.
July 12, 2016
IURTC realized a year-over-year jump of 43 spots, from 86th to 43rd, as it increased its annual number of patents from 25 to 47.
July 6, 2016
Officials at Indiana University Research and Technology Corp. have reported a year-over-year 72 percent increase in licensing agreements.
June 30, 2016
The National Institutes of Health has awarded grants totaling more than $1 million to two researcher scientists in the School of Health and Rehabilitation Sciences at Indiana University-Purdue University Indianapolis to study the effects of exercise on health conditions affecting millions of Americans.
June 20, 2016
Indiana University has announced that the Precision Health Initiative, a research initiative focused on patient-centered precision medicine therapies, is the first recipient of funding under the university's new $300 million Grand Challenges Program.